Nestle divests peanut allergy business Palforzia

admin 8 months ago No Comments

This post was originally published on this site

Nestle said it has offloaded Palforzia to Stallergenes Greer, a biopharmaceutical company which specializes in the diagnosis and treatment of allergies.

Nestle will receive milestone payments and ongoing royalties from Stallergenes Greer, it said.

Prev Article Next Article

Striking Kellogg workers could return after Christmas as tentative deal reached

admin December 16, 2021

Stock markets in the red: Here's why the Fed could cool the market today

admin December 14, 2022

Volkswagen's Mexico workers accept 9% raise deal in third vote

admin September 13, 2022

E.ON's CEO says Germany should boost domestic gas production

admin June 24, 2022

Asian Markets Mixed; Chinese Stocks Up as Manufacturing Activity Expands

admin April 1, 2020

S.Korea's Naver to acquire Poshmark in U.S. for $1.6 billion

admin October 3, 2022

Email

Related Posts

About The Author

admin